Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126682933	12668293	3	F	20160810	20160824	20160819	20160901	EXP		BR-ALEXION PHARMACEUTICALS INC.-A201606075	ALEXION		22.66	YR		M	Y	0.00000		20160901		CN	BR	BR

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126682933	12668293	1	PS	SOLIRIS	ECULIZUMAB	1	Intravenous (not otherwise specified)	900 MG, FOR 4 WEEKS							125166	900	MG	CONCENTRATE FOR SOLUTION FOR INFUSION
126682933	12668293	2	SS	SOLIRIS	ECULIZUMAB	1	Intravenous (not otherwise specified)	1200 MG, Q2W							125166	1200	MG	CONCENTRATE FOR SOLUTION FOR INFUSION	QOW

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126682933	12668293	1	Haemolytic uraemic syndrome

Outcome of event

Reactions reported

Event ID	CASEID	PT
126682933	12668293	Device related infection
126682933	12668293	Pyrexia
126682933	12668293	Seizure
126682933	12668293	Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
126682933	12668293	1	20160702	20160722	0
126682933	12668293	2	20160729		0